COMPANIES

More news
Novartis raised its 2024 earnings guidance for the third time this year

'Pure-play' Novartis Raises 2024 Financial Targets

A year after spinning off its generics business to become a "pure-player" developer of innovative medicines, Novartis registered a 15 percent increase in its core net profit to $4.1 billion during the July-September period, from the same quarter last year.
BP's third quarter performance was hit by lower oil prices and refining margins

Oil Giant BP Reports Drop In Third-quarter Net Profit

The group earlier this month flagged to markets that its latest earnings would take a sizeable hit after oil prices have fallen on concerns over Chinese demand and the prospect of higher crude production in 2025.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.